Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Progenics Pharmaceut (PGNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Best Relative Performance in the Biotechnology Industry Detected in Shares of Immunogen Inc (IMGN, MDXG, PGNX, ALDR, AKBA)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

MDXG : 17.11 (+2.21%)
PGNX : 5.93 (+6.65%)
ALDR : 9.55 (-1.55%)
AKBA : 15.36 (+1.32%)
IMGN : 6.10 (-2.87%)
Sangamo Therapeu is Among the Companies in the Biotechnology Industry with the Best Relative Performance (SGMO, PGNX, HRTX, EGRX, RTRX)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

SGMO : 10.40 (-7.14%)
PGNX : 5.93 (+6.65%)
EGRX : 55.39 (+2.38%)
RTRX : 23.38 (+3.91%)
HRTX : 15.60 (+1.30%)
Investor Network: Progenics Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 9, 2017 at...

PGNX : 5.93 (+6.65%)
BUYINS.NET: PGNX SqueezeTrigger Price is $6.07. There is $43,324,822 That Short Sellers Still Need To Cover.

BUYINS.NET / www.buyins.net is monitoring Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) in real time and just received an alert that PGNX is crossing above its primary SqueezeTrigger Price, the price that...

PGNX : 5.93 (+6.65%)
Shares of PGNX Down 30.4% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on March 30th, 2017 at $9.67. In approximately 2 months, Progenics Pharmaceuticals has returned 30.42% as of today's recent...

PGNX : 5.93 (+6.65%)
Progenics Pharmaceuticals Announces the Presentation of Data From Two Automated Bone Scan Index Studies at the 2017 ASCO Annual Meeting

Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced today the presentation of two...

PGNX : 5.93 (+6.65%)
Progenics Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference

Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, announced today that Mark R. Baker, Chief Executive...

PGNX : 5.93 (+6.65%)
Downtrend Call Working As Progenics Pharmaceuticals Stock Falls 33.5% (PGNX)

SmarTrend identified a Downtrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on March 30th, 2017 at $9.67. In approximately 2 months, Progenics Pharmaceuticals has returned 33.47% as of today's recent...

PGNX : 5.93 (+6.65%)
Progenics Pharmaceuticals Has Returned 28.1% Since SmarTrend Recommendation (PGNX)

SmarTrend identified a Downtrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on March 30th, 2017 at $9.67. In approximately 2 months, Progenics Pharmaceuticals has returned 28.09% as of today's recent...

PGNX : 5.93 (+6.65%)
Progenics Pharmaceuticals Shares Down 25.5% Since SmarTrend's Sell Call (PGNX)

SmarTrend identified a Downtrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on March 30th, 2017 at $9.67. In approximately 2 months, Progenics Pharmaceuticals has returned 25.50% as of today's recent...

PGNX : 5.93 (+6.65%)
Biotech Stocks on Investors' Radar -- Progenics Pharma, Dynavax Technologies, Intrexon, and Heat Biologics

Stock-Callers.com is currently reviewing the most recent performances of Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), Dynavax Technologies Corp. (NASDAQ: DVAX), Intrexon Corp. (NYSE: XON), and Heat Biologics...

HTBX : 0.50 (unch)
PGNX : 5.93 (+6.65%)
XON : 18.16 (-2.52%)
DVAX : 16.65 (+2.78%)
PetMed (PETS) Beats Earnings, Revenue Estimates in Q4

PetMed Express, Inc. (PETS) announced earnings per share of 37 cents for the fourth quarter of fiscal 2017, up 37% from the year-ago quarter's 27 cents.

PETS : 46.39 (-1.07%)
HOLX : 38.15 (-0.10%)
PGNX : 5.93 (+6.65%)
BAX : 61.44 (+1.05%)
Henry Schein (HSIC) Tops Q1 Earnings, Reaffirms '17 View

Henry Schein, Inc. (HSIC) reported adjusted earnings per share (EPS) of $1.76 in the first quarter of 2017, up 24.8% year over year.

HOLX : 38.15 (-0.10%)
PGNX : 5.93 (+6.65%)
HSIC : 169.05 (+0.66%)
BAX : 61.44 (+1.05%)
Haemonetics (HAE) Tops Q4 Earnings, Sales, Issues 2018 View

Haemonetics Corporation (HAE) reported adjusted earnings per share (EPS) of 39 cents in the fourth quarter of fiscal 2017, up 5.4% year over year.

HOLX : 38.15 (-0.10%)
PGNX : 5.93 (+6.65%)
BAX : 61.44 (+1.05%)
HAE : 42.80 (+0.47%)
Phibro (PAHC) Posts In Line Earnings in Q3, Revises View

Phibro Animal Health Corporation (PAHC) reported adjusted earnings per share (EPS) of 37 cents in the third quarter of fiscal 2017, down 7.5% year over year.

HOLX : 38.15 (-0.10%)
PGNX : 5.93 (+6.65%)
PAHC : 39.85 (+0.13%)
BAX : 61.44 (+1.05%)
Align Technology Invisalign Sales Strong, Currency Woes Stay

On May 5, we issued an updated research report on Align Technology (ALGN), which manufactures a system of clear aligner therapy.

HOLX : 38.15 (-0.10%)
PGNX : 5.93 (+6.65%)
BAX : 61.44 (+1.05%)
ALGN : 177.52 (-0.25%)
Qiagen Banks on Molecular Diagnostic amid Currency Woes

On May 4, we issued an updated research report on leading molecular diagnostic company, Qiagen N.V. (QGEN).

HOLX : 38.15 (-0.10%)
PGNX : 5.93 (+6.65%)
BAX : 61.44 (+1.05%)
QGEN : 31.53 (+0.54%)
CVS Down on Weak Earnings, Pharmacy Services Remains Strong

On May 5, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).

CVS : 79.66 (+0.70%)
HOLX : 38.15 (-0.10%)
PGNX : 5.93 (+6.65%)
BAX : 61.44 (+1.05%)
VWR Corp (VWR) Beats on Q1 Earnings, Awaits Merger Closure

VWR Corporation (VWR) reported first-quarter 2017 adjusted earnings per share (EPS) of 44 cents, reflecting a 10% rise from the year-ago quarter.

VWR : 33.01 (unch)
HOLX : 38.15 (-0.10%)
PGNX : 5.93 (+6.65%)
BAX : 61.44 (+1.05%)
Shares of PGNX Down 32.0% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on March 30th, 2017 at $9.67. In approximately 1 month, Progenics Pharmaceuticals has returned 32.02% as of today's recent...

PGNX : 5.93 (+6.65%)

Van Meerten Stock Picks

5 Mid Cap Picks
Today I wanted to find 5 Mid Cap Stocks with current momentum, so I used Barchart to sort the S&P 400 Mid Cap Index stocks first for the highest Weighted Alpha, then again for technical buy signal s of 80% or more.
CGNX +0.23 , IPGP +1.35 , NVR -3.87 , TTWO +1.46 , AAN +0.15
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Sep E-mini S&Ps ( ESU17 +0.17%) this morning are up +0.21% and European stocks are up +0.87% on economic optimism after Eurozone Q2 GDP rose at a +0.6% q/q pace, right on expectations. In addition, the UK labor... Read More

Chart of the Day

Chart of the Day

CryoPort (CYRX) is the Barchart Chart of the Day.  The specialty shipping company has a Trend Spotter buy signal, a Weighted Alpha of 430.32+ and gained 279.50% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures are trading fractionally higher this morning. They ended Tuesday trade with most contacts 4 1/2 to 8 cents in the red, on improved crop condition ratings. Maturity is still lagging. The USDA Crop Progress report showed that 16% of the ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.